Veliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative Disorders
National Cancer Institute (NCI)
National Cancer Institute (NCI)
OHSU Knight Cancer Institute
Roswell Park Cancer Institute
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Case Comprehensive Cancer Center